Benzinga

Benzinga Japan

Benzinga

Benzinga Japan

Benzinga

Benzinga Japan
金曜日, 9 04

Inspire Medical Systems Inc

INSPNYSE
Trade with Public
Trade with Public
$62.14
-0.93-1.47%
近くで: Sep 3, 5:00 PM EST
$62.14
N/A
時間外: 4:00 PM EST
概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

Inspire Medical Systems Analyst Price Targets

Wall Street analyst price targets and consensus rating for Inspire Medical Systems (INSP).

Price Target Range — 9 Quarters

Analyst Consensus — 15 Analysts

6Buy
8Hold
1Sell
Consensus RatingBuy# Analysts15Avg. Consensus PT$83Upside to Avg. PT+34.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
Aug 4, 2026JP MorganRobbie MarcusPT RaiseNeutral$54→$60
Aug 4, 2026MizuhoAnthony PetronePT RaiseOutperform$55→$65
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
JP Morgan Maintains Neutral on Inspire Medical Systems, Raises Price Target to $60

JP Morgan analyst Robbie Marcus maintains Inspire Medical Systems (NYSE:INSP) with a Neutral and raises the price target from $54 to $60.
Benzinga Newsdesk

PRO
Mizuho Maintains Outperform on Inspire Medical Systems, Raises Price Target to $65

Mizuho analyst Anthony Petrone maintains Inspire Medical Systems (NYSE:INSP) with a Outperform and raises the price target from $55 to $65.
Benzinga Newsdesk

PRO
Oppenheimer Upgrades Inspire Medical Systems to Outperform, Announces $85 Price Target

Oppenheimer analyst Suraj Kalia upgrades Inspire Medical Systems (NYSE:INSP) from Perform to Outperform and announces $85 price target.
Benzinga Newsdesk

PRO
Truist Securities Reiterates Hold on Inspire Medical Systems, Raises Price Target to $62

Truist Securities analyst Richard Newitter reiterates Inspire Medical Systems (NYSE:INSP) with a Hold and raises the price target from $54 to $62.
Benzinga Newsdesk

PRO
Evercore ISI Group Maintains In-Line on Inspire Medical Systems, Raises Price Target to $54

Evercore ISI Group analyst Daniel Markowitz maintains Inspire Medical Systems (NYSE:INSP) with a In-Line and raises the price target from $40 to $54.
Benzinga Newsdesk

Inspire Medical Systems Analysts Raise Their Forecasts Following Strong Q2 Results

INSPI beats expectations, raises FY26 guidance. Analysts raise price targets to $59 & $60. Stock jumps 14.6% in pre-market trading. #INSP
Avi Kapoor

データとAPI: Benzinga API · 株式ニュースAPI · アナリスト評価API · 企業ロゴAPI

市場データ提供元 Benzinga API

Benzinga

Benzinga Japan

ニュース

パートナーシップ

ベンジンガ・グローバル

© 2026 Benzinga | All Rights Reserved